Accessing the US Market – Key Development Considerations and Options for Market Entry for Japan-Based Biopharma Companies

GT Shareholder Wayne Elowe and Koichiro Oshashi will be speaking at "Accessing the US Market – Key Development Considerations and Options for Market Entry for Japan-Based Biopharma Companies." This insightful seminar is designed for Japanese biopharma firms aiming to secure FDA approval and enter the U.S. market. This event offers expert guidance from consultants and legal advisors on crafting effective development strategies and navigating U.S. market entry. Key topics include enhancing asset value through U.S. development strategies, ensuring regulatory and clinical readiness, and exploring various market entry models. This practical seminar aims to equip participants with the knowledge needed to maximize their product's potential in the U.S. market. A networking reception will take place after starting at 5:30 p.m.